首页> 外国专利> REDIRECTION OF CELLULAR IMMUNITY BY RECEPTOR CHIMERAS

REDIRECTION OF CELLULAR IMMUNITY BY RECEPTOR CHIMERAS

机译:嵌合体受体可重新定向细胞免疫

摘要

Disclosed is a method of directing a cellular response in a mammal by expressing in a cell of the mammal at least two chimeric receptors which trigger the specific recognition and destruction of an infective agent, a cell infected with an infective agent, a tumor or cancerous cell, or an autoimmune-generated cell. One of the expressed chimeric receptors includes an extracellular portion which is capable of specifically recognizing and binding the target cell or target infective agent and an intracellular or transmembrane portion which is capable of signalling the therapeutic cell to destroy a receptor-bound target cell or a receptor-bound target infective agent; and the second chimeric receptor includes an extracellular portion which is capable of specifically recognizing and binding the target cell or target infective agent and an intracellular portion which is derived from CD28. Also disclosed are pairs of useful chimeric receptors, cells which express the chimeric receptors, and DNA encoding the chimeric receptors.
机译:公开了一种通过在哺乳动物细胞中表达至少两种嵌合受体来指导哺乳动物细胞反应的方法,所述至少两种嵌合受体触发感染剂,感染了感染剂的细胞,肿瘤或癌细胞的特异性识别和破坏。 ,或自身免疫产生的细胞。表达的嵌合受体之一包括能够特异性识别并结合靶细胞或靶标感染剂的细胞外部分和能够向治疗细胞发信号以破坏结合受体的靶标细胞或受体的细胞内或跨膜部分。结合的目标传染物;第二嵌合受体包括能够特异性地识别并结合靶细胞或靶感染剂的细胞外部分和来源于CD28的细胞内部分。还公开了有用的嵌合受体对,表达嵌合受体的细胞和编码嵌合受体的DNA。

著录项

  • 公开/公告号HU225688B1

    专利类型

  • 公开/公告日2007-06-28

    原文格式PDF

  • 申请/专利权人 THE GENERAL HOSPITAL CORPORATION BOSTON;

    申请/专利号HU19980001873

  • 发明设计人 SEED BRIAN;ROMEO CHARLES;KOLANUS WALDEMAR;

    申请日1996-01-25

  • 分类号A61K48;C12N15/09;A61K35/14;A61K39;A61P37;C07K14/705;C07K14/725;C07K14/73;C07K14/735;C07K16/28;C07K19;C12N5;C12N5/06;C12N5/10;C12N15/12;

  • 国家 HU

  • 入库时间 2022-08-21 20:58:44

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号